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Molecules participating in insect immunity of Sarcophaga peregrina
By Shunji NATORI*1,†
(Communicated by Takao SEKIYA, M.J.A.)
Abstract: Pricking the body wall of Sarcophaga peregrina (ﬂesh ﬂy) larvae with a needle
activated the immune system of this insect and induced various immune molecules, including
antibacterial proteins, in the hemolymph. In this review, I summarize and discuss the functions of
these immune molecules, with particular emphasis on the dual roles of some of these molecules in
defense and development.
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Introduction
I have been studying insect immunity for nearly
40 years. Originally, my major in graduate study was
microbiology; however, during my stay at Yale
University, I learned much about Drosophila devel-
opment. At the end of December 1971, I was
appointed as an assistant professor at the University
of Tokyo, Faculty of Pharmaceutical Sciences, and
returned from Yale University where I stayed for
more than 3 years as a postdoctoral fellow. When I
accepted the position of assistant professor, I decided
to start a new project to study the molecular
mechanism of the diﬀerentiation of Drosophila
imaginal discs, with special reference to the function
of the molting hormone 20-hydroxyecdysone. How-
ever, to my great disappointment, I soon realized
that it was almost impossible to rear Drosophila in
our Faculty, because of the deserted research
environment produced during the University trou-
bles.
At that time, I encountered Sarcophaga pere-
grina, a big ﬂesh ﬂy, at the National Institute of
Health of Japan. This insect could be very easily
handled and could be reared, even under poor
experimental conditions, with dried milk, sugar cube
and water (adults), or pork liver (larvae). Moreover,
the amount of 20-hydroxyecdysone in Sarcophaga
larvae could be controlled by using the dry-wet
treatment, which is a great advantage in testing the
eﬀect of externally introduced 20-hydroxyecdysone.1)
When Sarcophaga larvae are kept under wet con-
ditions, secretion of 20-hydroxyecdysone from the
ring gland stops, whereas it starts again when they
are transferred to dry conditions.1) Therefore, I
decided to use Sarcophaga instead of Drosophila
and started investigating the eﬀect of 20-hydroxy-
ecdysone on imaginal disc diﬀerentiation by injecting
the hormone in the larval body cavity under wet
conditions. However, soon after starting the new
project, a simple casual experiment motivated me to
turn my attention to insect immunity.
In front of my working bench, one of my
colleagues was injecting various chemical compounds
to tumor-bearing mice to examine their chemo-
therapeutic eﬀect. He was extremely nervous about
sterilizing glass syringes in boiling water before their
use because tumor-bearing mice are susceptible to
bacterial infection. I used the same glass syringes to
inject 20-hydroxyecdysone into Sarcophaga larvae.
No infected or dead Sarcophaga appeared even when
the larvae were injected using nonsterilized syringes,
and almost 100% of the larvae pupated and
metamorphosed into adults.
From this result, a serious question came to my
mind: does larval hemolymph contain antibacterial
activity? I promptly examined this possibility. I
mixed the hemolymph from normal larvae with an
Escherichia coli suspension. After incubation, I
spread the mixture on agar plates, expecting that
no E. coli colony will form. In contrast to my
expectation, however, numerous bacterial colonies
appeared on the plates, indicating that no appreci-
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hemolymph. Incidentally, I performed the same
experiment using hemolymphs collected from larvae
injected with 20-hydroxyecdysone or insect saline
(control). Surprisingly, no bacterial colonies were
detected in both of these hemolymph groups.2)
This observation clearly indicated that normal
larvae do not have antibacterial activity, but
injecting them with foreign substances promptly
induced such activity. I was deeply impressed with
this observation, and decided to participate in insect
immunity studies, although I was quite unfamiliar
with the ﬁeld at that time. I was in my early 30s then.
In the past three decades, studies on self-defense
mechanisms of insects have developed greatly and
formed a special branch of insect study, called “insect
immunity”.
Sarcophaga immune molecules
We ﬁrst intended to isolate an inducible anti-
bacterial substance in the hemolymph of Sarcophaga
larvae. For this purpose, at least 100mL of hemo-
lymph was needed as a starting material. It was
possible to collect 30µL of hemolymph per larva by
decapitating each larva with ﬁne scissors and then
squeezing the body. Therefore, to collect 100mL of
hemolymph, more than 3,000 larvae had to be
squeezed. Moreover, each larva had to be injected
with 5µL of insect saline before hemolymph collection.
This was a very tedious and time-consuming process.
However, we later found that, instead of injection of
insect saline, mere pricking of larval body wall with a
hypodermic needle was suﬃcient to induce antibacte-
rial activity.3) This ﬁnding greatly accelerated the
process of hemolymph collection, and allowed the
collection of suﬃcient amounts of hemolymph for the
characterization of antibacterial activity. Throughout
this study, we learned that various proteins are
induced in the hemolymph when the larval body wall
was pricked. Many of these proteins were found to be
involved in insect immunity.4),5)
We assume that contact with bacteria is needed
to activate these immune protein genes. Since the
experiments were conducted under nonsterile con-
ditions, body pricking may have been suﬃcient to
introduce bacteria into the larval body. Therefore,
body pricking is equivalent to bacterial immuniza-
tion. Subsequent studies revealed that the promoter
region of these genes contains NF-5B binding motifs,
suggesting that their expression is regulated by a
family of transcription factors called the Rel pro-
teins.6)–8)
We have thus far puriﬁed and characterized 3
antibacterial proteins,9)–11) 1 humoral lectin,3) 1
antifungal protein (AFP),12) and 1 small antibacte-
rial compound (N-O-alanyl-5-S-glutathionyl-3,4-di-
hydroxyphenylalanine [5-S-GAD])13) as immune
molecules of Sarcophaga larvae. These molecules are
not normally present in the insect but are promptly
synthesized in response to bacterial immunization
(body pricking), except for AFP which is constitu-
tively present in the hemolymph of normal larvae.
A unique feature of these antibacterial proteins
is the presence of structurally related multiple
homologues. At least 3 homologues of sarcotoxin
I,14) 3 homologues of sarcotoxin II,15),16) and 3
homologues of sapecin17),18) have been identiﬁed.
Their genes form a tandem array in restricted
genomic regions, are simultaneously expressed in
response to bacterial infection, and prevent the
spread of bacteria in the body cavity.16),19) Sarco-
phaga lectin, AFP, and 5-S-GAD were also found to
be involved in insect immunity.20) In contrast to
antibacterial proteins, both Sarcophaga lectin and
AFP are single-gene proteins.
Function of Sarcophaga immune molecules
In this section, I will brieﬂy explain how
Sarcophaga immune molecules thus far identiﬁed
are involved in insect immunity. We found that
Sarcophaga synthesizes multiple antibacterial pro-
teins having diﬀerent bacterial speciﬁcity and kills
various invading bacteria at once, on emergency.
Furthermore, we found that it constructs a potent
anti-fungal system utilizing an inducible antibacterial
protein and basic AFP. These facts suggest that this
insect developed a sophisticated self-defense system
mobilizing a limited number of immune molecules
eﬀectively.
(a) Sarcotoxin I. The sarcotoxin I family is a
group of antibacterial proteins each consisting of 39
amino acid residues. At least 3 sarcotoxin I congeners
are present in immunized Sarcophaga larvae, and
their primary structures were determined from their
cDNA sequences (Fig. 1).14) We chemically synthe-
sized sarcotoxin IA and studied its mode of action.
Sarcotoxin IA is a bactericidal protein and its
minimum inhibitory concentration values for various
bacteria are shown in Table 1.9) Its bactericidal eﬀect
was detected both in growing and nongrowing
conditions.21) Generally, gram-negative bacteria are
more susceptible to sarcotoxin IA than gram-positive
bacteria. The N-terminal half of this molecule is rich
in positively charged amino acids and is hydrophilic,
S. NATORI [Vol. 86, 928whereas the C-terminal half is hydrophobic. Thus,
this molecule is amphiphilic and readily interacts
with the bacterial membrane.22)–25)
We found that sarcotoxin IA disrupts the
electrochemical membrane potential, resulting in
cessation of ATP synthesis and amino acid transport
in E. coli.22) These amphiphilic molecules likely form
channels in the bacterial membrane, causing its
perturbation and loss of function. We found that
the E. coli uncA mutant, which has a defect in
oxidative phosphorylation, is much less sensitive to
sarcotoxin IA than wild-type E. coli. This may be
because the uncA mutant does not require electro-
chemical gradient of protons for the synthesis of
ATP, as ATP is supplied by substrate-level phos-
phorylation. These results suggest that the bacter-
icidal eﬀect of sarcotoxin IA is mainly due to its
ability to disrupt electrochemical gradient of protons
and stop ATP synthesis. In fact, the cellular ATP
level of E. coli was shown to markedly decrease upon
treatment with sarcotoxin IA (Fig. 2).
(b) Sarcotoxin II. We have puriﬁed 3
homologues of sarcotoxin II (IIA to IIC) from the
Fig. 1. Amino acid sequences of sarcotoxin IA, IB, and IC.14) Charged amino acid residues are marked D or !, and hydrophobic amino
acid residues are underlined. Identical amino acid residues to those of sarcotoxin IA are indicated by dashes.
Table 1. Bacterial speciﬁcity of sarcotoxin IA9)
Sarcotoxin IA at various ﬁnal concentrations of below 1µg/mL was mixed with Difco antibiotic medium (A) or polypeptone solution
(P), and the minimum inhibitory concentration was determined.
Fig. 2. Eﬀect of sarcotoxin IA on the ATP pool of Escherichia
coli.22) Bacteria was suspended in 10mM phosphate buﬀer
(pH 6.0), containing 130mM NaCl, 0.1% bovine serum albumin,
and 0.4% glucose. The suspension was preincubated for 10min
at 37°C. Then, sarcotoxin IA was added at a ﬁnal concentration
of 10µg/mL. Samples were obtained at intervals, and ATP was
measured by the luciferin/luciferase assay. , control cells
treated with distilled water; , cells treated with sarcotoxin IA.
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mass of these proteins is about 24,000, which is
diﬀerent from that of sarcotoxin I. We examined the
mode of action of sarcotoxin IIA.26) A high concen-
tration of sarcotoxin IIA (100µg/mL) showed
bactericidal eﬀect when bacteria were in growing
conditions, but it did not kill the bacteria under
nongrowing conditions. This mode of action is
diﬀerent from that of sarcotoxin IA. At the concen-
tration of 25µg/mL in the medium, sarcotoxin IIA
showed a bacteriostatic eﬀect. The scanning electron
microscopic images of E. coli under these conditions
were very peculiar (Fig. 3). Sarcotoxin IIA-treated
cells elongated and had unusual projections or bulges
on their surface, which may have been due to
intracellular osmotic pressure. These bulges may
have been formed by the inhibition of peptidoglycan
synthesis by sarcotoxin IIA, and their surface
structure may be similar to that of spheroplasts
obtained by treating E. coli with lysozyme.
The antibacterial spectrum of sarcotoxin IIA is
very narrow; thus far, it has been shown to be eﬀective
only against a few gram-negative bacteria, including
E. coli, and ineﬀective against gram-positive bacteria.
(c) Sapecin. Sapecin is another bactericidal
protein of Sarcophaga, and at least 3 congeners
(sapecin, sapecin B, and sapecin C) have been
identiﬁed.17) Incidentally, we found that NIH-
Sape-4 cells, an established embryonic cell line of
Sarcophaga, synthesize and secrete sapecin into
the culture medium.11) Therefore, it was possible to
purify sapecin from the culture medium of NIH-
Sape-4 cells. Sapecin is a bactericidal protein that
consists of 40 amino acid residues, including 6 Cys
residues that form 3 intramolecular disulﬁde
bridges.27)–30) In contrast to sarcotoxin IA, gram-
positive bacteria are more sensitive to sapecin than
gram-negative bacteria.
Similar to sarcotoxin IA, the primary target of
sapecin was assumed to be the bacterial mem-
brane.31) Therefore, we prepared 2 types of liposomes
with similar phospholipid compositions to those of
the membranes of Staphylococcus aureus and E. coli,
respectively, each containing trapped glucose. We
examined the eﬀect of sapecin on these liposomes by
measuring glucose release.32) An increase in sapecin
concentration resulted in the release of glucose from
liposomes resembling the phospholipid composition
of the S. aureus membrane (i.e., formed from
phosphatidylglycerol and cardiolipin in a molar ratio
of 3:1). Liposomes prepared from phosphatidyleth-
Fig. 3. Scanning electromicroscopic images of E. coli cells treated with sarcotoxin IIA.26) (a) Intact bacteria. (b) and (c) Bacteria treated
with 25µg/mL of sarcotoxin IIA for 4h. Bars, 2µm.
Fig. 4. Release of glucose from liposomes in the presence of
sapecin.32) Two types of liposomes with entrapped glucose were
prepared from phospholipids resembling the phospholipid
composition of Staphylococcus aureus ( ) and E. coli ( ).
Increasing concentrations of sapecin were added to those
liposomes; the suspension was incubated for 30min at 22°C;
and the amount of glucose released from the liposomes was
measured.
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molar ratio of 7:2:1, resembling the phospholipids
composition of the E. coli membrane, were not
aﬀected, and no appreciable release of glucose was
detected under these conditions (Fig. 4). These
results explain why gram-positive S. aureus is more
sensitive to sapecin than gram-negative E. coli.
We found that sapecin has a high aﬃnity to
cardiolipin, which is a major acidic phospholipid of
the S. aureus membrane; however, its aﬃnity to
other acidic phospholipids was low. Thus, we assume
that the interaction between sapecin and cardiolipin
is a prerequisite for the bactericidal activity of
sapecin. To examine the involvement of membrane
cardiolipin in bacterial sensitivity to sapecin, we
performed further studies. Although E. coli is less
sensitive to sapecin than S. aureus, it becomes
sensitive to sapecin at suﬃciently high concentra-
tions. Therefore, we examined the eﬀect of sapecin on
an E. coli mutant with a defect in cardiolipin
synthesis. The cardiolipin content of this mutant
was less than 10% of that of wild-type E. coli. This
mutant was clearly more resistant to sapecin than the
wild type, suggesting that cardiolipin content is a
crucial factor for bacterial sensitivity to sapecin.
However, membrane cardiolipin content alone cannot
fully explain the preferential sensitivity of gram-
positive bacteria to sapecin. We found that the
lipopolysaccharide (LPS) of gram-negative bacteria
is an eﬀective barrier to sapecin. A rough mutant of
E. coli that lacks the polysaccharide chains of LPS
molecules was more sensitive to sapecin than the
wild-type strain. Moreover, E. coli became more
sensitive to sapecin when treated with EDTA (a
condition under which E. coli is known to lose more
than 60% of its LPS). Thus, LPS seems to be a
barrier to sapecin and contributes to gram-negative
bacteria being less sensitive to this bactericidal
protein than gram-positive bacteria. Similar to
sarcotoxin IA, sapecin is likely to disrupt membrane
functions, although its precise mechanism is still
unknown.33)
(d) Sarcophaga lectin. During studies on
bactericidal proteins in the hemolymph of immu-
nized Sarcophaga larvae, we detected hemaggluti-
nating activity in the same hemolymph. This
activity was speciﬁcally inhibited by galactose,
indicating that it is due to a galactose-binding lectin,
which we termed Sarcophaga lectin. We puriﬁed
Sarcophaga lectin to homogeneity by aﬃnity chro-
matography on galactose, and determined its pri-
mary structure by isolating its cDNA.3),34) Sarco-
phaga lectin is a large molecule with a molecular
mass of 190,000, consisting of 2 subunits with
molecular masses of 32,000 and 30,000, respectively,
in a molar ratio of 4:2. These subunits were found to
be essentially the same protein, and their diﬀerence
in molecular mass can be explained by their diﬀer-
ence in glycosylation.
We studied the physiological function of Sarco-
phaga lectin in insect immunity, and found that
it plays a role in the elimination of foreign cells
introduced in the larval body cavity.35)–37)
When sheep red cells were injected into larvae,
a signiﬁcant amount of Sarcophaga lectin was
promptly induced. The red cells were gradually lysed,
and eventually disappeared from the hemolymph.
However, when an antibody against Sarcophaga
lectin or galactose is injected simultaneously with
the red cells, cell lysis was greatly inhibited (Fig. 5),
indicating that Sarcophaga lectin is involved in the
elimination of invading foreign cells. Although lysis of
red cells occurred in the larval body cavity, Sarcoph-
aga lectin itself had no hemolytic activity. Therefore,
elimination of foreign cells is a complex process that
implicates Sarcophaga lectin.
(e) Antifungal protein. We found that the
hemolymph of Sarcophaga contains AFP.12) Unlike
antibacterial proteins, AFP is a constitutive compo-
nent of the larval hemolymph. We puriﬁed AFP, and
found that it is a histidine-rich protein consisting of
67 amino acid residues. AFP is a fungicidal protein; it
signiﬁcantly inhibits the growth of Candida albicans
but had no eﬀect on bacterial growth.12)
Fig. 5. Inhibition of lysis of sheep red cells injected into the
abdominal cavity of larvae, by an antibody against Sarcophaga
lectin or its hapten sugar.37) Percentage lysis of red cells was
determined 60min after their injection. To examine the eﬀect of
sugars, 5µL of 0.5M solutions of glucose and galactose were
injected. 1, saline; 2, control IgG; 3, antibody; 4, glucose; 5,
galactose.
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markedly enhanced in the presence of the antibacte-
rial protein sarcotoxin IA. We found that when
C. albicans was treated with a ﬁxed amount of AFP
(100µg/mL), their viability decreased with the
increase in the amount of sarcotoxin IA added,
although sarcotoxin IA (10µg/mL) alone had no
fungicidal activity against C. albicans under these
conditions (Fig. 6). This suggests that Sarcophaga
develops an eﬃcient antifungal system with constit-
utive AFP and inducible sarcotoxin IA when the
larval body wall was injured to allow invasion of
fungi.12) AFP and sarcotoxin IA possibly form a
complex having much higher antifungal activity than
AFP alone.
(f) 5-S-GAD. 5-S-GAD is a conjugate of
glutathione and O-alanyl dehydroxyphenylalanine
(Fig. 7).13) This compound has antibacterial activity,
and, similar to various antibacterial proteins, is an
inducible molecule.13) It seems to be rapidly synthe-
sized by tyrosinase from glutathione and O-alanyl
dehydroxyphenylalanine upon bacterial infection.
The antibacterial eﬀect of 5-S-GAD was found to
be due to the hydrogen peroxide produced from this
molecule. As hydrogen peroxide is an activator of Rel
family transcription factors, such as NF-5B, 5-S-
GAD may partly contribute to the activation of
antibacterial protein genes by producing hydrogen
peroxide. Besides its antibacterial activity, 5-S-GAD
was found to have various pharmacological functions,
including potent antioxidant and radical scavenger
activities.38)–46) Thus, 5-S-GAD is likely to be also
involved in wound healing and anti-inﬂammatory
processes upon damage to larval tissues and the body
wall.
Dual roles of an insect immune protein
in defense and development
We were able to determine the primary struc-
tures of various Sarcophaga immune proteins by
isolating their cDNAs. Using these cDNAs as probes,
it was possible to examine the expression of these
immune protein genes by northern blot hybrid-
ization. As expected, all of these genes were ex-
pressed in immunized larvae. However, some immune
protein genes were found to be normally expressed
at speciﬁc developmental stages of this insect.47)–49)
The major tissue expressing these genes was the fat
body, which is functionally equivalent to mammalian
liver and/or kidney. These genes were also found to
be expressed in some hemocyte species. Throughout
these studies, we found a novel feature of these
immune proteins for the ﬁrst time. In Sarcophaga,
some immune proteins seem to play 2 independent
roles.50),51) We found that Sarcophaga lectin and
sapecin are 2 convincing examples of these pro-
teins.52),53)
As described in the section on Sarcophaga
lectin, it is clear that this lectin is essential for the
elimination of foreign cells introduced in the larval
body cavity. On the other hand, northern blot
experiments revealed that the Sarcophaga lectin gene
is naturally expressed at 2 stages in the life cycle of
this insect, the embryonic stage and the early pupal
stage.47) Thus, this lectin was also expected to play a
role in these developmental stages.
Fig. 6. Synergism between antifungal protein (AFP) and sarco-
toxin IA.12) Candida albicans was incubated with 100µg/mL
AFP and increasing amounts of sarcotoxin IA to examine
viability. Colonies were counted after incubation for 2 days at
37°C. The numbers of colonies relative to those without AFP are
shown.
Fig. 7. Structure of 5-S-GAD.13)
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panied by the elimination of apoptotic cells. At the
pupal stage, most larval tissues disintegrate, and the
resulting unnecessary cells are eliminated.54) The cells
needed in ontogenetic processes are so-called “self”
cells. Unnecessary cells, labeled “nonself,” are rapidly
disintegrated. The mechanism of disintegration of
nonself cells may be similar to the elimination of
foreign cells, and Sarcophaga lectin may also play a
crucial role in this process. I believe that innate
immunity is required for the elimination of both
invading foreign cells and self-derived nonself cells in
insects, and Sarcophaga lectin is one of the key
molecules of innate immunity.
Sarcophaga lectin seems to be indispensable not
only for elimination of nonself cells but also for the
development of adult tissues from imaginal discs at
the pupal stage. When imaginal discs of Sarcophaga
were cultured in vitro in the presence of 20-
hydroxyecdysone, they diﬀerentiated and formed
adult structures similar to Drosophila imaginal discs.
The developmental stages of imaginal discs, such as
eversion, elongation, apolysis, and terminal diﬀer-
entiation, were easily distinguishable under a binoc-
ular microscope.52) We found that an antibody
against Sarcophaga lectin or galactose signiﬁcantly
interfered with the development of imaginal discs,
whereas control IgG or glucose did not, which
suggested that this lectin is indispensable for the
development of imaginal discs.52)
As this culture system does not contain any
component derived from Sarcophaga except imaginal
discs, these results suggest that imaginal discs
secreted Sarcophaga lectin during their diﬀerentia-
tion. We found that a signiﬁcant amount of
Sarcophagi lectin is synthesized by the imaginal discs
and secreted into the culture medium when they are
cultured in the presence of 20-hydroxyecdysone
(Fig. 8). Although imaginal disc cells were viable,
they did not synthesize Sarcophaga lectin when
cultured in the absence of the hormone. Therefore,
it is clear that imaginal discs secrete Sarcophaga
lectin in the presence of 20-hydroxyecdysone, and the
resulting lectin promotes their further development
in an autocrine manner.
Like Sarcophaga lectin, we found that the
antibacterial protein sapecin also plays roles in both
defense and development. Northern blot experiments
showed that the sapecin gene is transiently expressed
in the embryonic stage and early pupal stage without
any outside stimulus.49) This expression pattern is
similar to that of the Sarcophaga lectin gene.
We assume that sapecin acts as a growth factor
in normal development. As shown in Fig. 9, DNA
synthesis and cell number increased with the amount
of sapecin added to the culture medium of NIH-
Sape-4 cells, indicating that sapecin stimulates the
Fig. 8. Production of Sarcophaga lectin in the culture medium of
leg discs.55) Leg discs were cultured in the presence ( )o r
absence ( ) of 20-hydroxyecdysone. Samples of medium were
obtained at the indicated times, and the amount of Sarcophaga
lectin was measured by radioimmunoassay.
Fig. 9. Eﬀect of sapecin on the proliferation of NIH-Sape-4
cells.53) NIH-Sape-4 cells were cultured with various amounts of
sapecin. [3H]Thymidine was added to the medium after 24h,
and DNA was labeled for 24h. Then, cell number ( ) and DNA
radioactivity ( ) were measured.
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mentioned above, NIH-Sape-4 cells produce sapecin.
Embryonic cells possibly produce sapecin during
ontogenetic development, and sapecin stimulates cell
proliferation in an autocrine manner. Furthermore,
we also found that imaginal discs synthesize sapecin
in the presence of 20-hydroxyecdysone, suggesting
the participation of this protein in the diﬀerentiation
of imaginal discs.55) This function seems to be quite
similar to that of Sarcophaga lectin. Thus, sapecin
may also play 2 independent roles—in defense and
development (ontogeny)—like Sarcophaga lectin.
Insects possibly have the ability to mobilize a
single protein for various purposes. This may be a
new paradigm in insect biology, and may be extended
to other animal species. Drosophila Toll is known as a
receptor essential for the formation of the dorsoven-
tral axis in embryonic development. Incidentally, the
same receptor was found to induce drosomycin, an
antifungal protein, in innate immunity.56) Although
Toll is not an immune protein, this may be another
example of 1 protein having dual functions in insects.
Practical application of Sarcophaga
immune molecules
It became evident that some Sarcophaga im-
mune molecules have potential practical applica-
tions.57)–59) One is the creation of transgenic plants
with sarcotoxin IA cDNA, which have acquired
resistance to bacterial and fungal infection. For
instance, transgenic tobacco plants that express
sarcotoxin IA showed enhanced resistance to the
causative pathogens of wild-ﬁre disease (Pseudo-
monas syringae pv. tabaci) and bacterial soft rot
disease (Erwinia carotovora subsp. carotovora). An
example of infection with Pseudomonas syringae pv.
tabaci is shown in Fig. 10. Clearly, transgenic plants
have acquired resistance to this bacterium. Moreover,
transgenic plants expressing higher levels of sarco-
toxin IA were able to withstand fungal infection
(Rhizoctonia solani and Pythium aphanidermatum)
and remained healthy, whereas control plants died
under the same conditions. Thus, the use of
sarcotoxin IA cDNA made possible the breeding of
transgenic crop plants that are resistant to various
pathogenic bacteria and fungi. These transgenic
plants have potential agricultural applications.
On the other hand, 5-S-GAD was found to
have several pharmacological activities, based on its
antioxidant property. Especially, we found that it
signiﬁcantly represses cataract progression.46),60)
When rats were given diet containing 50% galactose,
the onset of cataract was observed after 7 days, and
lens opacities progressively worsened. After 28 days,
all of the lenses had developed severe cataract.
However, when galactose-fed rats received an instilla-
tion of 0.1–1.0% 5-S-GAD solution 4 times a day on a
daily basis, cataract progression was signiﬁcantly
retarded after 14 days. No mature cataract was
observed in the 5-S-GAD-treated groups even after
28 days (Fig. 11). A similar therapeutic eﬀect of 5-S-
GAD was detected in UV-B-induced cataract of rats.
Thus, 5-S-GAD may have potential to be developed as
an anticataractous ophthalmic solution. We assume
that the radical scavenger activity of 5-S-GAD is
implicated in the repression of cataract progression.
Perspective and future directions
It is believed that several millions of animal
species are living on Earth. Of these organisms, more
than 70% are insects and less than 4% are verte-
brates. Therefore, insects are extremely successful
Fig. 10. Resistance against bacterial pathogen attack in transgenic tobacco plants.58) The fully expanded upper leaves of tobacco plants
were wounded by using 10 ﬁne needles within a 10-mm circle, and inoculated with Pseudomonas syringae pv. tobaci, the pathogen for
wild-ﬁre disease. Leaves of sarcotoxin IA-expressing (left) and wild-type (right) plants are shown.
S. NATORI [Vol. 86, 934animals in terms of very high species abundance.
Insects have developed a sophisticated self-defense
mechanism, the so-called insect immunity, which is
now considered an innate immunity.61) Insect im-
munity is activated only when insects are infected
with microorganisms. As discussed in this article,
many immune molecules, including antibacterial
proteins, are induced when the body wall of
Sarcophaga larvae was pricked to allow bacterial
invasion. In this insect, the expression of these
immune protein genes is regulated by Rel family
transcription factors. These immune protein genes
are simultaneously activated by a single-shot body
pricking, which means that this insect is able to
readily develop a potent self-defense system against
various microorganisms.
Insect immunity is clearly indispensable for
the elimination of invading microorganisms. How-
ever, throughout this study, I am more and more
inclined to believe that the same immune system is
participating in the clearance of unnecessary cells or
tissue fragments produced during ontogenetic proc-
esses. We found that many immune protein genes are
dormant throughout the life cycle of Sarcophaga,
except in the early embryonic stage and early
pupal stage in which these genes are transiently
activated. Larval structures are formed throughout
the embryonic development, whereas adult struc-
tures are formed in the metamorphic process, which
takes place at the pupal stage. It is known that
many unnecessary cells are produced both at the
embryonic stage and the pupal stage. Especially at
the pupal stage, many larval tissues disintegrate
and new adult structures develop from imaginal
discs. Since many immune proteins are synthesized
at these stages, they must be functioning at these
stages.
The function of these proteins may be 2-fold.
One is elimination of self-derived nonself cells, and
the other is stimulation of construction of new tissues
from self cells. We showed that Sarcophaga lectin is
indispensable for imaginal disc diﬀerentiation and
sapecin stimulates proliferation of embryonic cells.
These suggest that both proteins participate in the
construction of new tissues from self cells. On the
other hand, Sarcophaga lectin participates in the
elimination of sheep red cells introduced into the
larval body cavity, and sapecin has the ability to kill
invading bacteria. Despite the absence of a direct
evidence, we believe that these proteins participate in
the elimination of self-derived nonself cells.
Studies on insect immunity have greatly pro-
gressed, and the molecular mechanisms of the
activation of immune protein genes have been well
understood. However, I think that 2 major issues
remain unsolved. One is about the antiviral protein
of insects. Do insects have a defense system against
viruses? Although antibacterial and antifungal pro-
teins have been extensively studied, very little
information is available on antiviral proteins in
insects. Thus, we should give much attention to the
antiviral system of insects. The other issue is about
the mechanism of immune tolerance against sym-
biotic microorganisms. About 60% of insect species
are believed to contain symbiotic microorganisms,
such as are bacteria or fungi. These symbiotic
microorganisms are passed on from ancestors to
descendants for many generations. Insects are usually
very sensitive to bacterial infection. Namely, they
develop an eﬃcient immune system almost instanta-
neously upon exogenous introduction of bacteria.
However, this immune system does not respond to
symbiotic microorganisms. How symbiotic micro-
organisms in insects escape from host immune
surveillance is a question that has to be solved in
the future.
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